been doing some research on competitors and what the phase trial is looking for
so the main competitor seems to be Avanex and edison pharma
and if someone can help me here - so this trial result is basically going to secure a partnering deal with a commercial pharma as opposed to going Phase 3 alone?
Neuren has undertaken and now completed a wide-ranging evaluation of strategic options, including partnering, assisted in this process by Leerink Partners, a leading US investment banking firm specializing in healthcare. A number of international pharmaceutical companies expressed interest in Neuren’s Rett syndrome and Fragile X syndrome programs. Detailed discussions with those companies have indicated that the results of the Rett syndrome trial, due in the first quarter of 2017, will be an important and valuable component of the trofinetide development package. Neuren recognizes the potential commercial value this could represent and therefore has determined that partnering in the major markets is best considered once the pediatric trial results are available.
NEU Price at posting:
8.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)